Prospects for immunotherapy of MHC class I-deficient tumours

0191552 - UMG-J 20033051 RIV CZ eng J - Journal Article
Bubeník, Jan
Prospects for immunotherapy of MHC class I-deficient tumours.
Folia Biologica. Roč. 49, č. 3 (2003), s. 95-99. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z5052915
Keywords : MHC class I * immunotherapy
Subject RIV: FD - Oncology ; Hematology
Impact factor: 0.527, year: 2003

More attention should be paid to the MHC class I status of the neoplasms during the elaboration of tumour immunotherapy protocols with regard to the possible cytokine therapy. Prospectively, the therapeutic role of the induction of MHC class I expression by demethylation and acetylation agents prior to or simultaneously with the immunotherapy should also be investigated.
Permanent Link: http://hdl.handle.net/11104/0087295